ArticleMethodsX2026
Isolation and characterization of microplastics from human blood samples by confocal RAMAN microscopy.
Article in MethodsX, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microplastics (MPs) and nanoplastics (NPs) are emerging environmental contaminants increasingly detected in human tissues and fluids, highlighting the need for reliable analytical methods capable of isolating and characterizing these particles in complex biological matrices while reducing contamination risks. This work presents a systematic, integrative, and reproducible protocol for detecting MPs in human blood using confocal Raman microscopy. The method incorporates strict contamination-control measures, includes negative and positive controls to ensure analytical reliability, and provides reference Raman spectra from commonly used clinical and laboratory materials to identify potential sources of cross-contamination. Spectral data are compared using the open-source platform Open Specy, enabling similarity matching with an extensive polymer database and improving the confidence of particle identification. Application of the protocol enabled the detection and characterization of MPs in human blood samples, identifying polymers such as polystyrene (PS), ethylene-vinyl acetate (EVA), and polyethylene (PE). Overall, this protocol demonstrates high specificity for detecting MPs in human blood and provides a robust framework for future exposure studies.•Provides a contamination-controlled analytical framework for MP detection in human blood.•Integrates reference materials and controls to ensure data reliability and trace contamination sources.•Uses open-source spectral comparison to support confident polymer identification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.